Women's Health
News
USPSTF holds firm on postmenopausal hormone recommendations
The central message of updated recommendations from the U.S. Preventive Services Task Force’s on using hormone therapy to prevent chronic...
Latest News
Hormone therapy–depression link may depend on mode of administration
Registry study suggests different effects from local and systemic types of hormone therapy plus age.
Latest News
Nicotine blocks estrogen production in women’s brains
There is evidence to suggest that there is a complex interaction between sex and steroid hormones and the reward effect of nicotine, modulated by...
News
Plant-based diet cut hot flashes 78%: WAVS study
Postmenopausal women who ate a reduced-fat, vegan diet supplemented with soy experienced far fewer hot flashes and improved quality of live,...
Conference Coverage
Early estrogen loss increases cardiovascular risk in women
Clinicians should especially be aware of functional hypothalamic amenorrhea as a condition that could increase women’s risk of cardiovascular...
Latest News
Maternal deaths show that ‘racism does exist among physicians’
The researchers concluded that Black women had a 53% increased chance of dying during childbirth in a hospital, even after adjusting for factors...
Conference Coverage
Nonhormonal drug fezolinetant found safe for hot flashes in yearlong study
Although additional safety studies await fezolinetant before it heads to the FDA for approval, it appears to be on its way to offering women an...
Conference Coverage
Menopause symptoms negatively affect women’s work
With 13% of women reporting a major impact on their work from menopause symptoms, the study still may underestimate the effects of this life...
News
It’s about location: PCOS symptoms differ depending where you live
Women with PCOS in California were more likely to have hyperandrogenemia than were those in Alabama, but age and BMI weren’t factors, nor was race...
Latest News
Dermatologists fear effects of Dobbs decision for patients on isotretinoin, methotrexate
The iPLEDGE work group has not yet issued any specific statements on the implications of the Dobbs decision on prescribing isotretinoin.